Replagal has been approved by Health Canada as of February 2017..
Exciting news for the CFA Community – Replagal has been approved by Health Canada as of February 2017 and all patients have been transitioned from the REP-081 study at this point. Replagal is a long-term Enzyme Replacement Therapy (ERT), the infusion will be given every 2 weeks, treatment time being approximately 4o minutes. It is wonderful to have this product approved and available to Canadian patients. The delivery system will be the same, for more information click on the link to read the patient information leaflet.